Molecular basis for the presence of glycosylated onco-foetal fibronectin in oral carcinomas: The production of glycosylated onco-foetal fibronectin by carcinoma cells

Oral Oncology

Volumn 43, Issue 3, 2007, Pages 301-309

  Wandall, Hans H ^a   Dabelsteen, Sally ^a   Sørensen, Jens Ahm ^b   Krogdahl, Annelise ^b   Mandel, Ulla ^a   Dabelsteen, Erik ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Extracellular matrix; Fibronectin; Glycosylation; Oral cancer

Indexed keywords

FIBRONECTIN; N ACETYLGALACTOSAMINYLTRANSFERASE; ONCOFETAL ANTIGEN;

ALTERNATIVE RNA SPLICING; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL;

ACTINS; BIOCOMPATIBLE MATERIALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELLS, CULTURED; COLLAGEN; DRUG COMBINATIONS; FIBROBLASTS; FIBRONECTINS; GLYCOSYLATION; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; LAMININ; MOUTH NEOPLASMS; MUSCLE, SMOOTH; PROTEOGLYCANS; SIALYLTRANSFERASES;

EID: 33846892238     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.03.005     Document Type: Article

References (36)

1. Mandel U., Gaggero B., Reibel J., Therkildsen M.H., Dabelsteen E., and Clausen H. Oncofetal fibronectins in oral carcinomas: correlation of two different types. APMIS 102 9 (1994) 695-702
2. Berndt A., Borsi L., Hyckel P., and Kosmehl H. Fibrillary co-deposition of laminin-5 and large unspliced tenascin-C in the invasive front of oral squamous cell carcinoma in vivo and in vitro. J Cancer Res Clin Oncol 127 5 (2001) 286-292
3. Matsuura H., and Hakomori S. The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. Proc Natl Acad Sci USA 82 19 (1985) 6517-6521
4. Pankov R., and Yamada K.M. Fibronectin at a glance. J Cell Sci 115 (2002) 3861-3863
5. Sakai T., Larsen M., and Yamada K.M. Fibronectin requirement in branching morphogenesis. Nature 423 6942 (2003) 876-881
6. Astrof S., Crowley D., George E.L., Fukuda T., Sekiguchi K., Hanahan D., et al. Direct test of potential roles of EIIIA and EIIIB alternatively spliced segments of fibronectin in physiological and tumor angiogenesis. Mol Cell Biol 24 19 (2004) 8662-8670
7. Hynes R.O. Fibronectins: a family of complex and versatile adhesive glycoproteins derived from a single gene. Harvey Lect 81 (1985) 133-152
8. Kornblihtt A.R., Pesce C.G., Alonso C.R., Cramer P., Srebrow A., Werbajh S., et al. The fibronectin gene as a model for splicing and transcription studies. FASEB J 10 2 (1996) 248-257
9. Matsuura H., Takio K., Titani K., Greene T., Levery S.B., Salyan M.E., et al. The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. Unique structural requirement for the antigenic specificity provided by a glycosylhexapeptide. J Biol Chem 263 7 (1988) 3314-3322
10. Xia P., and Culp L.A. Adhesion activity in fibronectin's alternatively spliced domain EDa (EIIIA) and its neighboring type III repeats: oncogene-dependent regulation. Exp Cell Res 213 1 (1994) 253-265
11. Ting K.M., Rothaupt D., McCormick T.S., Hammerberg C., Chen G., Gilliam A.C., et al. Overexpression of the oncofetal Fn variant containing the EDA splice-in segment in the dermal-epidermal junction of psoriatic uninvolved skin. J Invest Dermatol 114 4 (2000) 706-711
12. Berndt A., Kosmehl H., Mandel U., Gabler U., Luo X., Celeda D., et al. TGF beta and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin. Histochem J 27 12 (1995) 1014-1020
13. Kosmehl H., Berndt A., and Katenkamp D. Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects. Virchows Arch 429 6 (1996) 311-322
14. Kilian O., Dahse R., Alt V., Zardi L., Rosenhahn J., Exner U., et al. Expression of EDA+ and EDB+ fibronectin splice variants in bone. Bone 35 6 (2004) 1334-1345
15. David L., Mandel U., Clausen H., and Sobrinho-Simoes M. Immunohistochemical expression of oncofetal fibronectin in benign and malignant lesions of the stomach. Eur J Cancer 29A 14 (1993) 2070-2071
16. Szell M., Bata-Csorgo Z., Koreck A., Pivarcsi A., Polyanka H., Szeg C., et al. Proliferating keratinocytes are putative sources of the psoriasis susceptibility-related EDA+ (extra domain A of fibronectin) oncofetal fibronectin. J Invest Dermatol 123 3 (2004) 537-546
17. Matsuura H., Greene T., and Hakomori S. An alpha-N-acetylgalactosaminylation at the threonine residue of a defined peptide sequence creates the oncofetal peptide epitope in human fibronectin. J Biol Chem 264 18 (1989) 10472-10476
18. Schwientek T., Bennett E.P., Flores C., Thacker J., Hollmann M., Reis C.A., et al. Functional conservation of subfamilies of putative UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferases in Drosophila, Caenorhabditis elegans, and mammals. One subfamily composed of l(2)35Aa is essential in Drosophila. J Biol Chem 277 25 (2002) 22623-22638
19. Wandall H.H., Hassan H., Mirgorodskaya E., Kristensen A.K., Roepstorff P., Bennett E.P., et al. Substrate specificities of three members of the human UDP-N-acetyl-alpha-d-galactosamine:polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3. J Biol Chem 272 38 (1997) 23503-23514
20. Bennett E.P., Hassan H., Mandel U., Mirgorodskaya E., Roepstorff P., Burchell J., et al. Cloning of a human UDP-N-acetyl-alpha-d-galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat. J Biol Chem 273 46 (1998) 30472-30481
21. Mandel U., Hassan H., Therkildsen M.H., Rygaard J., Jakobsen M.H., Juhl B.R., et al. Expression of polypeptide GalNAc-transferases in stratified epithelia and squamous cell carcinomas: immunohistological evaluation using monoclonal antibodies to three members of the GalNAc-transferase family. Glycobiology 9 1 (1999) 43-52
22. Dabelsteen E., Gron B., Mandel U., and Mackenzie I. Altered expression of epithelial cell surface glycoconjugates and intermediate filaments at the margins of mucosal wounds. J Invest Dermatol 111 4 (1998) 592-597
23. Dabelsteen E., and Fejerskov O. Loss of epithelial blood group antigen-A during wound healing in oral mucous membrane. Acta Pathol Microbiol Scand [A] 82 3 (1974) 431-434
24. Argueso P., Spurr-Michaud S., Russo C.L., Tisdale A., and Gipson I.K. MUC16 mucin is expressed by the human ocular surface epithelia and carries the H185 carbohydrate epitope. Invest Ophthalmol Vis Sci 44 6 (2003) 2487-2495
25. Rheinwald J.G., and Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6 3 (1975) 331-343
26. Sorensen T., White T., Wandall H.H., Kristensen A.K., Roepstorff P., and Clausen H. UDP-N-acetyl-alpha-d-galactosamine:polypeptide N-acetylgalactosaminyltransferase. Identification and separation of two distinct transferase activities. J Biol Chem 270 41 (1995) 24166-24173
27. Inoue T., Nabeshima K., Shimao Y., Meng J.Y., and Koono M. Regulation of fibronectin expression and splicing in migrating epithelial cells: migrating MDCK cells produce a lesser amount of, but more active, fibronectin. Biochem Biophys Res Commun 280 5 (2001) 1262-1268
28. Warner G.C., Reis P.P., Jurisica I., Sultan M., Arora S., Macmillan C., et al. Molecular classification of oral cancer by cDNA microarrays identifies overexpressed genes correlated with nodal metastasis. Int J Cancer 110 6 (2004) 857-868
29. Berois N., Mazal D., Ubillos L., Trajtenberg F., Nicolas A., Sastre-Garau X., et al. UDP-N-acetyl-d-galactosamine:polypeptide N-acetylgalactosaminyltransferase-6 as a New Immunohistochemical Breast Cancer Marker. J Histochem Cytochem 54 3 (2006) 317-328
30. Loridon-Rosa B., Vielh P., Matsuura H., Clausen H., Cuadrado C., and Burtin P. Distribution of oncofetal fibronectin in human mammary tumors: immunofluorescence study on histological sections. Cancer Res 50 (1990) 1608-1612
31. Blaustein M, Pelisch F, Coso OA, Bissell MJ, Kornblihtt AR, Srebrow A. Mammary epithelial-mesenchymal interactions regulates fibronectin alternative splicing via phosphatidylinositol 3-kinase. J Biol Chem, in press.
32. Lewis M.P., Lygoe K.A., Nystrom M.L., Anderson W.P., Speight P.M., Marshall J.F., et al. Tumor-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br J Cancer 90 (2004) 822-832
33. Huhtala P., Humphries M.J., McCarthy J.B., Tremble P.M., Werb Z., and Damsky C.H. Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol 129 3 (1995) 867-879
34. Zhang Y., Lu H., Dazin P., and Kapila Y. Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin alphav mediate survival signals through focal adhesion kinase. J Biol Chem 279 46 (2004) 48342-48349
35. Margulis A., Zhang W., lt-Holland A., Pawagi S., Prabhu P., Cao J., et al. Loss of intercellular adhesion activates a transition from low-to high-grade human squamous cell carcinoma. Int J Cancer 118 4 (2006) 821-831
36. Kapila Y.L., Niu J., and Johnson P.W. The high affinity heparin-binding domain and the V region of fibronectin mediate invasion of human oral squamous cell carcinoma cells in vitro. J Biol Chem 272 (1997) 18932-18938